A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.
Our scientists have discovered that neuroblastoma cells can produce a cellular ‘kryptonite’ that seems to sap the power from nearby immune cells.
Read Professor Andy Pearson’s story, exploring his career researching childhood cancer and what the future holds for the BEACON neuroblastoma trial.
Neuroblastoma is a type of childhood cancer and our researchers are pioneering new clinical trials to tackle aggressive forms of the disease – how does it work?
Category: Science blog December 10, 2009
Cancer in children is not common. And although this is something to be thankful for, it can make things a…